|
mRNA expression of somatostatin receptor subtypes SSTR-2, SSTR-3, and SSTR-5 and its significance in pancreatic cancer
|
31 January 2020 |
|
LNCaP Prostate Cancer Growth In Vivo: Oncostatic Effects of Melatonin as Compared to Hypoxia and Reoxygenation
|
29 January 2020 |
|
Antiproliferative Effects of 1α-OH-vitD3 in Malignant Melanoma: Potential Therapeutic implications
|
28 January 2020 |
|
Different routes and formulations of melatonin in critically ill patients. A pharmacokinetic randomized study
|
24 January 2020 |
|
Somatostatin derivative (smsDX) targets cellular metabolism in prostate cancer cells after androgen deprivation therapy
|
24 January 2020 |
|
Melatonin Pharmacological Blood Levels Increase Total Antioxidant Capacity in Critically Ill Patients
|
24 January 2020 |
|
Melatonin Regulates Breast Cancer Progression by the lnc010561/miR-30/FKBP3 Axis
|
22 January 2020 |
|
Renal Neuroendocrine Neoplasms: A Single-center Experience
|
22 January 2020 |
|
Somatostatin and somatostatin analogues reduce PDGF-induced endometrial cell proliferation and motility
|
21 January 2020 |
|
Vitamin D deficiency in patients admitted to the general ward with breast, lung, and colorectal cancer in Buenos Aires, Argentina
|
20 January 2020 |